image showing signpost with text saying we are here to support your evidence-based product generation

A fee-based consultancy service to developers of:

  • pharmaceuticals
  • biopharmaceuticals
  • medical devices
  • diagnostics

We work with you in the early stages of product development. Our mission is to encourage you to consider the relative clinical and cost effectiveness of your products. These considerations can then inform your development strategy.

Make an enquiry

 

Our advice helps you prepare for NICE evaluations and supports discussions with payers and commissioners to enable market access.

Engaging with scientific advice can:

  • help you develop evidence that demonstrates the value of your product
  • provide detailed feedback on your clinical, economic development and evidence generation plans
  • provide insights from NICE-appointed experts
  • advise on the advantages and disadvantages of different options
  • help to integrate cost-effectiveness considerations into your evidence generation plans
  • help companies understand health technology assessments, and the perspective of decision makers, at our educational seminars and events.

To find out more about our wide range of services, choose from one of the options below and read our frequently asked questions.

You can find out more about the team on our biographies page.

Advise Me prize opens 27 June

  • Are you a healthcare SME, academic research group or charity?
  • Are you developing a transformative healthcare product for the NHS?
  • Could your product improve health outcomes, save money for the NHS or improve efficiency?
  • Would you like our input on your evidence development plans?

If so, apply for the NICE Advise Me prize – win a light scientific advice service worth £15,000. More information and the application form will be available here from 27 June.


Image of a pill

Pharmaceutical products

Standard scientific advice

Detailed advice from NICE and a panel of appointed experts.

 

NICE-MHRA scientific advice

Joint regulatory advice from the Medicines and Healthcare products Regulatory Agency and NICE Scientific Advice.

 

HTA-EMA scientific advice

Advice from the European Medicines Agency in parallel with NICE and other European Health Technology Assessment bodies.

 

Advice for small and medium-sized companies

A concise, more affordable version of our standard advice process.

Read our FAQs
Image of a heart beat

Devices and diagnostics

Standard scientific advice

Detailed advice from NICE and a panel of appointed experts.

 

Advice for small and medium-sized companies

A concise, more affordable version of our standard advice process.

Read our FAQs
Image of a seminar

Seminars, events and speaking engagements

25 May 2017 - Nottingham

Your NICE submission for devices and diagnostics - what you need to know

This introductory course will be the perfect opportunity for developers of devices to find out how we assess value.

15 June 2017 - Manchester

Advanced Workshop: for developers of pharmaceuticals

Gain insight into engaging with our technology appraisal process, factors relevant to decision-making, producing a submission and seeking advice from NICE

See all events